Immunocytologic staining of cytokeratin in bone marrow aspirates to detect micrometastatic cells fails in patients with metastatic urologic carcinoma

International Journal of Oncology

Volumn 11, Issue 6, 1997, Pages 1197-1201

  Schwaibold, Hartwig ^a   Wenck, Siegrun ^a   Huland, Edith ^a   Huland, Hartwig ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Bone marrow aspirates; Cytokeratin; Micrometastasis

Indexed keywords

CYTOKERATIN; IMMUNOGLOBULIN IDIOTYPE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; BONE MARROW CELL; CENTRIFUGATION; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RELAPSE; URINARY TRACT CANCER;

EID: 0030776012     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.6.1197     Document Type: Article

References (12)

1. Schlimok G and Riethmüller G: Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin Cancer Biol 1: 207-215, 1990.
2. Mansi JL, Berger U, Wilson P, Shearer R and Coombes RC: Detection of tumor cells in bone marrow of patients with prostatic carcinoma by immunocytochemical techniques. J Urol 139: 545-548, 1988.
3. Pantel K, Schlimok G, Kutter D, Schaller G, Genz T, Wiebecke B, Backmann R, Funke I and Riethmüller G: Frequent down-reguation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res 51: 4712-4715, 1991.
4. Oberneder R, Riesenberg R, Kriegmaier M, Bitzer U, Klammert R, Schneede P, Hofstetter A, Riethmüller G and Pantel K: Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol Res 22: 3-8, 1994.
5. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O and Riethmüller G: Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non small-cell lung cancer without overt metastases. Lancet 347: 649-653, 1996.
6. Mansi JL, Berger U, McDonnell T, Pople A, Royter Z, Gazet JC and Coombes RC: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7: 445-449, 1989.
7. Cote RJ, Rosen PP, Hakes TB, Sedira M, Bazinet M, Kinne DW, Old LJ and Osborne MP: Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12: 333-340, 1988.
8. Göttlinger HG, Funke I, Johnson JP, et al: The epithelial cell surface antigen 17-IA, a target for antibody mediated tumor therapy: its biological nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38: 47-53, 1986.
9. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J and Riethmüller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization and prognostic significance. J Clin Oncol 8: 831-837, 1990.
10. Huland E, Huland H, Meier Th, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM and Schmitz-Draeger BJ: Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder. J Urol 146: 1631-1636, 1991.
11. Stahel RA, Mabry M, Skarin AT, Speak J and Bernal SD: Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3: 455-461, 1985.
12. Shin SS, Sheibani K, Kezirian J, Nademanee A, Forman SJ, Lee SK and Winberg CD: Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sections. Hum Pathol 23: 686-694, 1992.